Introduction – Company Background

GuangXin Industrial Co., Ltd. is a specialized manufacturer dedicated to the development and production of high-quality insoles.

With a strong foundation in material science and footwear ergonomics, we serve as a trusted partner for global brands seeking reliable insole solutions that combine comfort, functionality, and design.

With years of experience in insole production and OEM/ODM services, GuangXin has successfully supported a wide range of clients across various industries—including sportswear, health & wellness, orthopedic care, and daily footwear.

From initial prototyping to mass production, we provide comprehensive support tailored to each client’s market and application needs.

At GuangXin, we are committed to quality, innovation, and sustainable development. Every insole we produce reflects our dedication to precision craftsmanship, forward-thinking design, and ESG-driven practices.

By integrating eco-friendly materials, clean production processes, and responsible sourcing, we help our partners meet both market demand and environmental goals.

Core Strengths in Insole Manufacturing

At GuangXin Industrial, our core strength lies in our deep expertise and versatility in insole and pillow manufacturing. We specialize in working with a wide range of materials, including PU (polyurethane), natural latex, and advanced graphene composites, to develop insoles and pillows that meet diverse performance, comfort, and health-support needs.

Whether it's cushioning, support, breathability, or antibacterial function, we tailor material selection to the exact requirements of each project-whether for foot wellness or ergonomic sleep products.

We provide end-to-end manufacturing capabilities under one roof—covering every stage from material sourcing and foaming, to precision molding, lamination, cutting, sewing, and strict quality control. This full-process control not only ensures product consistency and durability, but also allows for faster lead times and better customization flexibility.

With our flexible production capacity, we accommodate both small batch custom orders and high-volume mass production with equal efficiency. Whether you're a startup launching your first insole or pillow line, or a global brand scaling up to meet market demand, GuangXin is equipped to deliver reliable OEM/ODM solutions that grow with your business.

Customization & OEM/ODM Flexibility

GuangXin offers exceptional flexibility in customization and OEM/ODM services, empowering our partners to create insole products that truly align with their brand identity and target market. We develop insoles tailored to specific foot shapes, end-user needs, and regional market preferences, ensuring optimal fit and functionality.

Our team supports comprehensive branding solutions, including logo printing, custom packaging, and product integration support for marketing campaigns. Whether you're launching a new product line or upgrading an existing one, we help your vision come to life with attention to detail and consistent brand presentation.

With fast prototyping services and efficient lead times, GuangXin helps reduce your time-to-market and respond quickly to evolving trends or seasonal demands. From concept to final production, we offer agile support that keeps you ahead of the competition.

Quality Assurance & Certifications

Quality is at the heart of everything we do. GuangXin implements a rigorous quality control system at every stage of production—ensuring that each insole meets the highest standards of consistency, comfort, and durability.

We provide a variety of in-house and third-party testing options, including antibacterial performance, odor control, durability testing, and eco-safety verification, to meet the specific needs of our clients and markets.

Our products are fully compliant with international safety and environmental standards, such as REACH, RoHS, and other applicable export regulations. This ensures seamless entry into global markets while supporting your ESG and product safety commitments.

ESG-Oriented Sustainable Production

At GuangXin Industrial, we are committed to integrating ESG (Environmental, Social, and Governance) values into every step of our manufacturing process. We actively pursue eco-conscious practices by utilizing eco-friendly materials and adopting low-carbon production methods to reduce environmental impact.

To support circular economy goals, we offer recycled and upcycled material options, including innovative applications such as recycled glass and repurposed LCD panel glass. These materials are processed using advanced techniques to retain performance while reducing waste—contributing to a more sustainable supply chain.

We also work closely with our partners to support their ESG compliance and sustainability reporting needs, providing documentation, traceability, and material data upon request. Whether you're aiming to meet corporate sustainability targets or align with global green regulations, GuangXin is your trusted manufacturing ally in building a better, greener future.

Let’s Build Your Next Insole Success Together

Looking for a reliable insole manufacturing partner that understands customization, quality, and flexibility? GuangXin Industrial Co., Ltd. specializes in high-performance insole production, offering tailored solutions for brands across the globe. Whether you're launching a new insole collection or expanding your existing product line, we provide OEM/ODM services built around your unique design and performance goals.

From small-batch custom orders to full-scale mass production, our flexible insole manufacturing capabilities adapt to your business needs. With expertise in PU, latex, and graphene insole materials, we turn ideas into functional, comfortable, and market-ready insoles that deliver value.

Contact us today to discuss your next insole project. Let GuangXin help you create custom insoles that stand out, perform better, and reflect your brand’s commitment to comfort, quality, and sustainability.

🔗 Learn more or get in touch:
🌐 Website: https://www.deryou-tw.com/
📧 Email: shela.a9119@msa.hinet.net
📘 Facebook: facebook.com/deryou.tw
📷 Instagram: instagram.com/deryou.tw

High-performance insole OEM China

Are you looking for a trusted and experienced manufacturing partner that can bring your comfort-focused product ideas to life? GuangXin Industrial Co., Ltd. is your ideal OEM/ODM supplier, specializing in insole production, pillow manufacturing, and advanced graphene product design.

With decades of experience in insole OEM/ODM, we provide full-service manufacturing—from PU and latex to cutting-edge graphene-infused insoles—customized to meet your performance, support, and breathability requirements. Our production process is vertically integrated, covering everything from material sourcing and foaming to molding, cutting, and strict quality control.ODM pillow production factory in Taiwan

Beyond insoles, GuangXin also offers pillow OEM/ODM services with a focus on ergonomic comfort and functional innovation. Whether you need memory foam, latex, or smart material integration for neck and sleep support, we deliver tailor-made solutions that reflect your brand’s values.

We are especially proud to lead the way in ESG-driven insole development. Through the use of recycled materials—such as repurposed LCD glass—and low-carbon production processes, we help our partners meet sustainability goals without compromising product quality. Our ESG insole solutions are designed not only for comfort but also for compliance with global environmental standards.Pillow ODM design company in Taiwan

At GuangXin, we don’t just manufacture products—we create long-term value for your brand. Whether you're developing your first product line or scaling up globally, our flexible production capabilities and collaborative approach will help you go further, faster.Taiwan insole ODM full-service provider factory

📩 Contact us today to learn how our insole OEM, pillow ODM, and graphene product design services can elevate your product offering—while aligning with the sustainability expectations of modern consumers.Latex pillow OEM production in Indonesia

Confocal microscopy image of a triple culture of pancreatic ductal adenocarcinoma (PDAC) cells, macrophages, and pancreatic stellate cells embed and growing within the engineered matrix. Credit: Professor Alvaro Mata, University of Nottingham An international team of scientists has created a three-dimensional (3D) pancreatic cancer tumor model in the laboratory, combining a bioengineered matrix and patient-derived cells that could be used to develop and test targeted treatments. In a new study published today (September 24, 2021) in Nature Communications, researchers from the University of Nottingham, Queen Mary University of London, Monash University and Shanghai Jiao Tong University have created a multicellular 3D microenvironment that uses patient-derived cells to recreate the way tumor cells grow in pancreatic cancer and respond to chemotherapy drugs.  Pancreatic cancer is very difficult to treat, particularly as there are no signs or symptoms until the cancer has spread. It can be resistant to treatment and the survivial rate is low compared to other cancers, with only a 5-10% survival rate five years after diagnosis.  The study was led by Professors Alvaro Mata from the University of Nottingham (UK), Daniela Loessner from Monash University (Australia) and Christopher Heeschen from Shanghai Jiao Tong University (China). Dr. David Osuna de la Peña, a lead researcher on the project, said: “There are two main obstacles to treating pancreatic cancer – a very dense matrix of proteins and the presence of highly resistant cancer stem cells (CSCs) that are involved in relapse and metastasis. In our study, we have engineered a matrix where CSCs can interact with other cell types and together behave more like they do in the body, opening the possibility to test different treatments in a more realistic manner.” There is a need for improved 3D cancer models to study tumor growth and progression in patients and test responses to new treatments. At present, 90% of successful cancer treatments tested pre-clinically fail in the early phases of clinical trials and less than 5% of oncology drugs are successful in clinical trials.  Pre-clinical tests mostly rely on a combination of two-dimensional (2D) lab-grown cell cultures and animal models to predict responses to treatment. However, conventional 2D cell cultures fail to mimic key features of tumor tissues and interspecies differences can result in many successful treatments in animal hosts being ineffective in humans.  Consequently, novel experimental 3D cancer models are needed to better recreate the human tumor microenvironment and incorporate patient-specific differences. Self-assembly is the process by which biological systems controllably assemble multiple molecules and cells into functional tissues. Harnessing this process, the team created a new hydrogel biomaterial made with multiple, yet specific, proteins found in pancreatic cancer. This mechanism of formation enables incorporation of key cell types to create biological environments that can emulate features of a patient’s tumor.  Professor Mata adds: “Using models of human cancer is becoming more common in developing treatments for the disease, but a major barrier to getting them into clinical applications is the turnaround time. We have engineered a comprehensive and tuneable ex vivo model of pancreative ductal adenocarcinoma (PDAC) by assembling and organizing key matrix components with patient-derived cells. The models exhibit patient-specific transcriptional profiles, CSC functionality, and strong tumourigenicity; overall providing a more relevant scenario than Organoid and Sphere cultures. Most importantly, drug responses were better reproduced in our self-assembled cultures than in the other models. We believe this model moves closer to the vision of being able to take patient tumor cells in hospital, incorporate them into our model, find the optimum cocktail of treatments for a particular cancer and deliver it back to the patient – all within a short timeframe. Although this vision for precision medicine for treating this disease is still a way off, this research provides a step towards realizing it.” Reference: “Bioengineered 3D models of human pancreatic cancer recapitulate in vivo tumour biology” by David Osuna de la Peña, Sara Maria David Trabulo, Estelle Collin, Ying Liu, Shreya Sharma, Marianthi Tatari, Diana Behrens, Mert Erkan, Rita T. Lawlor, Aldo Scarpa, Christopher Heeschen, Alvaro Mata and Daniela Loessner, 24 September 2021, Nature Communications. DOI: 10.1038/s41467-021-25921-9

Comparison of bird, reptile, and dinosaur skulls. Credit: Alec Wilken, Casey Holiday 3D modeling reveals that as bird brains grew larger, it led to changes in jaw muscles and joint mechanics—enabling the development of a more flexible and efficient feeding system in modern birds. Modern birds are the closest living relatives of dinosaurs. If you look at flightless birds like chickens and ostriches, which walk upright on two legs, or predators like eagles and hawks with sharp talons and keen vision, the resemblance to small theropod dinosaurs, like the Velociraptors made famous by Jurassic Park, is hard to miss. Still, birds differ from their reptilian ancestors in several key ways. One major evolutionary shift was the development of larger brains, which led to significant changes in skull size and shape. Now, new research from the University of Chicago and the University of Missouri reveals how these changes influenced the way birds move and use their beaks, mechanical adaptations that helped them thrive in diverse environments and evolve into the wide variety of bird species we see today. Animation of a bird skull, showing muscle forces. Credit: Alec Wilken, Casey Holiday The benefits of ‘wiggly’ skulls Modern birds, as well as other animals like snakes and fishes, have skulls with jaws and palates that aren’t rigid and fixed in place like those in mammals, turtles, or non-avian dinosaurs. Alec Wilken, a graduate student in integrative biology at UChicago and lead author of the new study, calls this kind of flexible skull “wiggly.” He says this characteristic makes it that much harder to figure out how the pieces work together. “Just because you have a joint there, that doesn’t mean that you know how it moves,” Wilken said. “So, you also have to think about how muscles are going to be pulling on the joint, what kind of torque they have, and how other joints in the head limit the mobility.” Wilken joined the project in 2015 when he was an undergraduate at the University of Missouri. Casey Holliday, PhD, Associate Professor of Pathology and Anatomical Sciences at University of Missouri, received a grant from the National Science Foundation (NSF) to study how the skulls, jaw muscles, and feeding mechanics changed along the transition from dinosaurs to birds, and Wilken joined his lab to help. Animation of a theropod dinosaur skull, showing muscle forces. Credit: Alec Wilken, Casey Holiday The team began by taking CT scans of a variety of fossils and skeletons from modern-day birds and related reptiles like alligators. Using the data from these images, they then built 3D models to calculate the mechanics of the skulls and jaws in action — muscle sizes and placements, their movements, and the physics involved in how they all fit together. One of the key differences between modern birds and other animals is that they have what’s called “cranial kinesis”: the ability to move different parts of the skull independently. This gives birds an evolutionary advantage by literally expanding their palates to eat different kinds of foods or use their beaks as a multifunctional tool. “Having a wiggly head like this really gives them a lot of evolutionary benefits,” Wilken said. Parrots, for example, can use their beaks to help climb; the extra torque helps other birds crack nuts and seeds. “In some ways, the beak functions like a surrogate hand, but being able to move the palate around while eating is also mission critical to helping them acquire food and survive.” A cascade of changes from dinosaurs to birds When the team analyzed data from the 3D models, they saw that as brain and skull sizes increased in non-avian theropod dinosaurs, muscles shifted into different positions that allowed the palate to separate and become mobile. These changes in turn, increased muscle force, which powers cranial kinesis in most modern-day birds. “We see this cascade of changes that happened along the dinosaur to bird transition,” Holliday said. “A large part of it hinges upon when birds evolved a relatively large brain. Just like in humans, bigger brains drive a lot of changes in the skull.” As paleontologists discover more details about dinosaurs, the dividing line between them and modern birds becomes murky (yes, birds are technically dinosaurs, but we’re speaking in broad terms here). Scientists used to think feathers were the key, but now we know that many bona fide dinosaurs had feathers, too. Flight also evolved more than once, and of course, many well-known, classic dinos could fly as well. However, flexible skulls and palates appeared later than transitional dinosaur/bird creatures like Archaeopteryx, and Holliday thinks that may become a key distinction. “Cranial kinesis might be one of the clear dividing lines between modern birds and their more dinosaur-like bird ancestors.” Reference: “Avian cranial kinesis is the result of increased encephalization during the origin of birds” by Alec T. Wilken, Kaleb C. Sellers, Ian N. Cost, Julian Davis, Kevin M. Middleton, Lawrence M. Witmer and Casey M. Holliday, 17 March 2025, Proceedings of the National Academy of Sciences. DOI: 10.1073/pnas.2411138122 Funding: U.S. National Science Foundation

A new computer program, Codetta, can read the genome sequence of any organism and determine its genetic code. This has the potential to aid scientists in understanding genetic code evolution and interpreting the genetic code of newly sequenced organisms. Yekaterina “Kate” Shulgina was a first year student in the Graduate School of Arts and Sciences, looking for a short computational biology project so she could check the requirement off her program in systems biology. She wondered how genetic code, once thought to be universal, could evolve and change. That was 2016 and today Shulgina has come out the other end of that short-term project with a way to decipher this genetic mystery. She describes it in a new paper in the journal eLife with Harvard biologist Sean Eddy. The report details a new computer program that can read the genome sequence of any organism and then determine its genetic code. The program, called Codetta, has the potential to help scientists expand their understanding of how the genetic code evolves and correctly interpret the genetic code of newly sequenced organisms. “This in and of itself is a very fundamental biology question,” said Shulgina, who does her graduate research in Eddy’s Lab. The genetic code is the set of rules that tells the cells how to interpret the three-letter combinations of nucleotides into proteins, often referred to as the building blocks of life. Almost every organism, from E. coli to humans, uses the same genetic code. It’s why the code was once thought to be set in stone. But scientists have discovered a handful of outliers — organisms that use alternative genetic codes – exist where the set of instructions are different. This is where Codetta can shine. The program can help to identify more organisms that use these alternative genetic codes, helping shed new light on how genetic codes can even change in the first place. “Understanding how this happened would help us reconcile why we originally thought this was impossible… and how these really fundamental processes actually work,” Shulgina said. Already, Codetta has analyzed the genome sequences of over 250,000 bacteria and other single-celled organisms called archaea for alternative genetic codes, and has identified five that have never been seen. In all five cases, the code for the amino acid arginine was reassigned to a different amino acid. It’s believed to mark the first time scientists have seen this swap in bacteria and could hint at evolutionary forces that go into altering the genetic code. The researchers say the study marks the largest screening for alternative genetic codes. Codetta essentially analyzed every genome that’s available for bacteria and archaea. The name of the program is a cross between the codons, the sequence of three nucleotides that forms pieces of the genetic code, and the Rosetta Stone, a slab of rock inscribed with three languages. The work marks a capstone moment for Shulgina, who spent the past five years developing the statistical theory behind Codetta, writing the program, testing it, and then analyzing the genomes. It works by reading the genome of an organism and then tapping into a database of known proteins to produce a likely genetic code. It differs from other similar methods because of the scale at which it can analyze genomes. Shulgina joined Eddy’s lab, which specializes in comparing genomes, in 2016 after coming to him for advice on the algorithm she was designing to interpret genetic codes. Until now, no one has done such a broad survey for alternative genetic codes. “It was great to see new codes, because for all we knew, Kate would do all this work and there wouldn’t turn out to be any new ones to find,” said Eddy, who’s also a Howard Hughes Medical Investigator. He also noted the potential of the system to be used to ensure the accuracy of the many databases that house protein sequences. “Many protein sequences in the databases these days are only conceptual translations of genomic DNA sequences,” Eddy said. “People mine these protein sequences for all sorts of useful stuff, like new enzymes or new gene editing tools and whatnot. You’d like for those protein sequences to be accurate, but if the organism is using a nonstandard code, they’ll be erroneously translated.” The researchers say the next step of the work is to use Codetta to search for alternative codes in viruses, eukaryotes, and organellar genomes like mitochondria and chloroplasts. “There’s still a lot of diversity of life where we haven’t done this systematic screening yet,” Shulgina said. Reference: “A computational screen for alternative genetic codes in over 250,000 genomes” by Yekaterina Shulgina and Sean R Eddy, 9 November 2021, eLife. DOI: 10.7554/eLife.71402

DVDV1551RTWW78V